This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

P16_INFECTIONS_SPECIFIC_PERINA_PERIOD

Other congenital infectious and parasitic diseases

Endpoint Browser

P16_OTH_CONGN_INFECTIOUS_PARASITIC_DISEA

No definition available.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — P37 Cause of death: ICD-10 — P37 2 out of 7 registries used, show all original rules.	6
4. Check minimum number of events None	6
5. Include endpoints None	6
6. Filter based on genotype QC (FinnGen only)	6

Control definitions (FinnGen only)

Control exclude: P16_INFECTIONS_SPECIFIC_PERINA_PERIOD

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: P3
Name in latin: Alii morbi bacteriales et parasitarii congeniti

NAME	P16_OTH_CONGN_INFECTIOUS_PARASITIC_DISEA
CONTROL_EXCLUDE	P16_INFECTIONS_SPECIFIC_PERINA_PERIOD
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	P37
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	P37
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other congenital infectious and parasitic diseases based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Not enough data for upset table.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	156	73	83
Only index persons	104	51	53
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	-	0.09	0.00
Only index persons	0.12	0.23	0.01

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6	6	-
Unadjusted period prevalence (%)	0.00	0.00	-
Median age at first event (years)	40.33	40.33	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40758558) Short blood count panel - Blood

0.00

0.75

0.0

10.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

0.00

0.49

0.0

1.9

—

(3019150) Specific gravity of Urine by Refractometry

0.00

0.48

0.0

6.0

—

(3026493) Urate [Moles/volume] in Serum or Plasma

0.00

0.48

0.0

5.5

—

311.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.00

0.24

0.0

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

0.00

0.24

0.0

2.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

0.00

0.24

0.0

10.5

—

4.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

0.00

0.24

0.0

1.4

—

(3000991) Gas panel - Venous blood

0.00

0.24

0.0

12.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

0.00

0.23

0.0

12.6

—

6.0

—

(3012544) pH of Venous blood

0.00

0.23

0.0

12.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

0.00

0.23

0.0

6.4

—

0.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.00

0.23

0.0

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

0.00

0.23

0.0

12.6

—

5.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

0.00

0.23

0.0

2.4

—

(3025941) Bacteria identified in Stool by Culture

0.00

0.0

1.0

—

(3022313) Gas panel - Capillary blood

0.00

0.0

10.5

—

(3009343) pH of Capillary blood

0.00

0.0

13.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

0.00

0.0

13.8

—

5.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.0

2.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

0.00

0.0

9.3

—

234.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

0.00

0.0

10.2

—

24.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

0.00

0.0

9.3

—

25.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

3.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

0.00

0.0

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.00

0.0

1.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

0.00

0.0

1.0

—

(40761535) Cells panel - Urine sediment

0.00

0.0

4.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

0.00

0.0

1.8

—

81.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

0.00

0.0

2.4

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

0.00

0.0

1.4

—

(40768797) Stomach Pathology biopsy report

0.00

0.0

1.8

—

(3000492) Spirometry study

0.00

0.0

1.6

—

(3000330) Specific gravity of Urine by Test strip

0.00

0.0

3.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.00

0.0

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

0.00

0.0

4.9

—

427.0

—

(3028026) IgM [Mass/volume] in Serum or Plasma

0.00

0.0

4.4

—

1.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

0.00

0.0

9.5

—

101.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

0.00

0.0

9.6

—

106.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.0

7.0

—

196.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

0.00

0.0

23.6

—

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

0.00

0.0

1.8

—

35.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

0.00

0.0

12.2

—

10.3

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

0.00

0.0

11.4

—

5.6

—

(3003327) Ova and parasites identified in Stool by Light microscopy

0.00

0.0

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

0.00

0.0

16.0

—

25.8

—

(3003396) Base excess in Arterial blood by calculation

0.00

0.0

11.4

—

2.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.0

1.2

—

(3022145) Colonoscopy Study observation

0.00

0.0

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.00

0.0

8.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

0.00

0.0

3.0

—

1.9

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

0.00

0.0

10.4

—

124.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.0

7.8

—

109.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

0.00

0.0

11.4

—

17.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

0.00

0.0

14.0

—

40.6

—

(3017732) Neutrophils [#/volume] in Blood

0.00

0.0

1.1

—

4.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.00

0.0

1.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

0.00

0.0

1.9

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3005719) IgG [Mass/volume] in Serum or Plasma

0.00

0.0

7.4

—

10.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

0.00

0.0

7.8

—

349.4

—

(3042936) Bacteria identified in Isolate by Culture

0.00

0.0

4.3

—

Mortality – FinRegistry

↥

Association

Association between endpoint P16_OTH_CONGN_INFECTIOUS_PARASITIC_DISEA and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_OTH_CONGN_INFECTIOUS_PARASITIC_DISEA.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: P16_OTH_CONGN_INFECTIOUS_PARASITIC_DISEA – Other congenital infectious and parasitic diseases

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Other congenital infectious and parasitic diseases

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints